Toosizadeh Nima, Harati Homayoon, Yen Tzu-Chuan, Fastje Cindy, Mohler Jane, Najafi Bijan, Dohm Michael
Arizona Center on Aging, Department of Medicine, University of Arizona, Tucson, AZ, USA; Interdisciplinary Consortium on Advanced Motion Performance (iCAMP), Department of Surgery, College of Medicine, University of Arizona, Tucson, AZ, USA.
Interdisciplinary Consortium on Advanced Motion Performance (iCAMP), Department of Surgery, College of Medicine, University of Arizona, Tucson, AZ, USA.
Clin Biomech (Bristol). 2016 Nov;39:100-108. doi: 10.1016/j.clinbiomech.2016.10.007. Epub 2016 Oct 11.
This study examined short- and long-term improvements in motor performance, quantified using wearable sensors, in response to facet spine injection in degenerative facet osteoarthropathy patients.
Adults with confirmed degenerative facet osteoarthropathy were recruited and were treated with medial or intermediate branch block injection. Self-report pain, health condition, and disability (Oswestry), as well as objective motor performance measures (gait, balance, and timed-up-and-go) were obtained in five sessions: pre-surgery (baseline), immediately after the injection, one-month, three-month, and 12-month follow-ups. Baseline motor performance parameters were compared with 10 healthy controls.
Thirty patients (age=50 (14) years) and 10 controls (age=46 (15) years) were recruited. All motor performance parameters were significantly different between groups. Results showed that average pain and Oswestry scores improved by 51% and 24%, respectively among patients, only one month after injection. Similarly, improvement in motor performance was most noticeable in one-month post-injection measurements; most improvements were observed in gait speed (14% normal walking, P<0.02), hip sway within balance tests (63% eyes-open P<0.01), and turning velocity within the timed-up-and-go test (28%, P<0.02). Better baseline motor performance led to better outcomes in terms of pain relief; baseline turning velocity was 18% faster among the responsive compared to the non-responsive patients.
Spinal injection can temporarily (one to three months) improve motor performance in degenerative facet osteoarthropathy patients. Successful pain relief in response to treatment is independent of demographic characteristics and initial pain but dependent on baseline motor performance. Immediate self-reported pain relief is unrelated to magnitude of gradual improvement in motor performance.
本研究探讨了在退行性小关节骨关节炎患者中,使用可穿戴传感器量化的运动表现的短期和长期改善情况,这些改善是对小关节脊柱注射的反应。
招募确诊为退行性小关节骨关节炎的成年人,并接受内侧或中间分支阻滞注射治疗。在五个阶段获取自我报告的疼痛、健康状况和残疾情况(奥斯维斯特里指数),以及客观的运动表现指标(步态、平衡和起身行走计时测试):手术前(基线)、注射后即刻、1个月、3个月和12个月随访。将基线运动表现参数与10名健康对照者进行比较。
招募了30名患者(年龄=50(14)岁)和10名对照者(年龄=46(15)岁)。两组之间所有运动表现参数均有显著差异。结果显示,注射后仅1个月,患者的平均疼痛和奥斯维斯特里指数评分分别改善了51%和24%。同样,运动表现的改善在注射后1个月的测量中最为明显;在步态速度(正常行走时提高14%,P<0.02)、平衡测试中的髋部摆动(睁眼时提高63%,P<0.01)以及起身行走计时测试中的转身速度(提高28%,P<0.02)方面观察到了最大程度的改善。更好的基线运动表现导致在疼痛缓解方面有更好的结果;与无反应患者相比,有反应患者的基线转身速度快18%。
脊柱注射可在短期内(1至3个月)改善退行性小关节骨关节炎患者的运动表现。治疗后成功的疼痛缓解与人口统计学特征和初始疼痛无关,但取决于基线运动表现。即时自我报告的疼痛缓解与运动表现的逐渐改善幅度无关。